Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder

Most guidelines recommend long-term, indefinite neuroleptic (or antipsychotic) treatment for people with schizophrenia, recurrent psychosis or bipolar disorder, on the basis that these medications reduce the chance of relapse. However, neuroleptics have significant adverse effects, including sexual...

Descripción completa

Detalles Bibliográficos
Autores principales: Moncrieff, Joanna, Gupta, Swapnil, Horowitz, Mark Abie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Discontinuing Psychotropic Medications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338640/
https://www.ncbi.nlm.nih.gov/pubmed/32670542
http://dx.doi.org/10.1177/2045125320937910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338640/
https://www.ncbi.nlm.nih.gov/pubmed/32670542
http://dx.doi.org/10.1177/2045125320937910

Ejemplares similares